Enlargement of Cerebral Ventricles as an Early Indicator of Encephalomyelitis

Lepore, Stefano; Waiczies, Helmar; Hentschel, Jan; Ji, Yiyi; Skodowski, Julia; Pohlmann, Andreas; Millward, Jason M.; Paul, Friedemann; Wuerfel, Jens; Niendorf, Thoralf; Waiczies, Sonia
August 2013
PLoS ONE;Aug2013, Vol. 8 Issue 8, p1
Academic Journal
Inflammatory disorders of the central nervous system such as multiple sclerosis and acute disseminated encephalomyelitis involve an invasion of immune cells that ultimately leads to white matter demyelination, neurodegeneration and development of neurological symptoms. A clinical diagnosis is often made when neurodegenerative processes are already ongoing. In an attempt to seek early indicators of disease, we studied the temporal and spatial distribution of brain modifications in experimental autoimmune encephalomyelitis (EAE). In a thorough magnetic resonance imaging study performed with EAE mice, we observed significant enlargement of the ventricles prior to disease clinical manifestation and an increase in free water content within the cerebrospinal fluid as demonstrated by changes in T2 relaxation times. The increase in ventricle size was seen in the lateral, third and fourth ventricles. In some EAE mice the ventricle size started returning to normal values during disease remission. In parallel to this macroscopic phenomenon, we studied the temporal evolution of microscopic lesions commonly observed in the cerebellum also starting prior to disease onset. Our data suggest that changes in ventricle size during the early stages of brain inflammation could be an early indicator of the events preceding neurological disease and warrant further exploration in preclinical and clinical studies.


Related Articles

  • Central nervous system inflammatory demyelinating disorders of childhood. Kamate, Mahesh; Chetal, Vivek; Tonape, Venkatesh; Mahantshetti, Niranjana; Hattiholi, Virupaxi // Annals of Indian Academy of Neurology;Oct-Dec2010, Vol. 13 Issue 4, p289 

    Background and Objectives: Childhood Central Nervous System (CNS) inflammatory demyelinating disorders (CIDD) are being diagnosed more commonly now. There is ambiguity in the use of different terms in relation to CIDD. Recently, consensus definitions have been proposed so that there is...

  • Neuroprotection in Multiple Sclerosis: A Therapeutic Approach. Maghzi, Amir-Hadi; Minagar, Alireza; Waubant, Emmanuelle // CNS Drugs;2013, Vol. 27 Issue 10, p799 

    Multiple sclerosis (MS) is a demyelinating disease of the central nervous system that is pathologically characterized by inflammatory demyelination and neurodegeneration. Axonal damage, along with neuronal loss, occurs from disease onset and may lead to progressive and permanent disability. In...

  • Disease Modifying Therapy in Multiple Sclerosis. Williams, U. E.; Oparah, S. K.; Philip-Ephraim, E. E. // ISRN Otolaryngology;2014, p1 

    Multiple sclerosis is an autoimmune disease of the central nervous system characterized by inflammatory demyelination and axonal degeneration. It is the commonest cause of permanent disability in young adults. Environmental and genetic factors have been suggested in its etiology. Currently...

  • Focal and diffuse cortical degenerative changes in a marmoset model of multiple sclerosis. Pomeroy, I. M.; Jordan, E. K.; Frank, J. A.; Matthews, P. M.; Esiri, M. M. // Multiple Sclerosis (13524585);May2010, Vol. 16 Issue 5, p537 

    Background: Degenerative features, such as neuronal, glial, synaptic and axonal loss, have been identified in neocortical and other grey matter structures in patients with multiple sclerosis, but mechanisms for neurodegeneration are unclear. Cortical demyelinating lesions are a potential cause...

  • Neurodegeneration in multiple sclerosis is a process separate from inflammation: Yes. Louapre, CĂ©line; Lubetzki, Catherine // Multiple Sclerosis Journal;Nov2015, Vol. 21 Issue 13, p1626 

    The article discusses debates about the causes of neurodegeneration in multiple sclerosis (MS), a type of central nervous system (CNS) inflammatory disease. Topics discussed include how inflammation and neurodegeneration interplay over the disease course, the potential factors that influence...

  • A differential diagnosis of central nervous system demyelination: beyond multiple sclerosis. Eckstein, Christopher; Saidha, Shiv; Levy, Michael // Journal of Neurology;May2012, Vol. 259 Issue 5, p801 

    Although multiple sclerosis (MS) is the most common demyelinating disorder of the central nervous system (CNS), it lacks any definitive diagnostic test. Instead, diagnosis of MS primarily depends upon clinical criteria, supported by abnormalities characteristic of MS on para-clinical...

  • Understanding inflammation's role in the pathogenesis of multiple sclerosis. Burgess, Megan // British Journal of Neuroscience Nursing;Feb2010, Vol. 6 Issue 2, p60 

    MS is an immune-mediated disease affecting the central nervous system (CNS); this article reviews current understanding of the pathology which underpins this disease. The primary focus for immune 'attack' within the CNS is myelin, a lipoprotein produced by oligodendrocytes which forms a coating...

  • Emerging Treatments for Multiple Sclerosis. Siatskas, Chris; Bernard, Claude // Australasian Science;Oct2007, Vol. 28 Issue 9, p18 

    The article provides information about multiple sclerosis (MS) and possible treatments for the disease. According to the author, MS is a debilitating disease that affects the central nervous system of a patient. Emerging treatments for curing MS includes the replacing the immune system with stem...

  • Candidate autoantigens in multiple sclerosis. Schmidt, S. // Multiple Sclerosis (13524585);Jun99, Vol. 5 Issue 3, p147 

    Multiple sclerosis is an inflammatory demyelinating CNS disease of putatively autoimmune origin. Novel models of experimental autoimmune encephalomyelitis (EAE) have demonstrated that T cells specific for various myelin and even nonmyelin proteins are potentially encephalitogenic. The...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics